Immunity and human malignant melanoma

June 1970
British Medical Journal;6/27/1970, Vol. 2 Issue 5712, p743
Academic Journal
No abstract available.


Related Articles

  • Autologous Melanoma Vaccine Induces Inflammatory Responses in Melanoma Metastases: Relevance to Immunologic Regression and Immunothererapy. Murphy, George F.; Radu, Antoaneta; Kaminer, Michael; Berd, David // Journal of Investigative Dermatology;Mar1993, Vol. 100 Issue 3, p335S 

    The article reports that autologous melanoma vaccine induces inflammatory responses in melanoma metastases. Human primary malignant melanoma is often accompanied by a host response of infiltrating lymphocytes suggestive of tumor antigen-induced immunity and correlated in some tumors with...

  • In This Issue... Huff, J. Clark // Journal of Investigative Dermatology;Aug91, Vol. 97 Issue 2, p163 

    This article presents information about critical growth control mechanism for melanoma. Immune defenses are thought to play some role in preventing the development and spread of human malignancies. The high incidence of malignancies and the often aggressive nature of cancer in patients...

  • The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Lebedeva, Irina V.; Zao-zhung Su; Yonmee Chang; Kintada, Shinichi; Reed, John C.; Fisher, Paul B. // Oncogene;1/24/2002, Vol. 21 Issue 5, p708 

    Analyzes the effects of ectopic expression of mda-7, administered by means of a replication-incompetent adenovirus, on the growth of human melanoma cells. Development of malignant melanoma in humans; Background on human melanoma cells; Infection of metastatic melanoma cells.

  • Immunostimulation and Immunoinhibition of Premalignant Lesions. Prehn, Richmond T. // Theoretical Biology & Medical Modelling;2007, Vol. 4, p6 

    Background The immune reaction may be either stimulatory or inhibitory to tumor growth, depending upon the local ratio of immune reactants to tumor cells. Hypothesis A tumor-stimulatory immune response may be essential for survival of a neoplasm in vivo and for the biological progression from a...

  • Innovations in treating melanoma. Roehr, Bob // Dermatology Times;Apr2007, Vol. 28 Issue 4, p88 

    The article focuses on the effect of human immune responses in treating melanoma. According to doctor Marie-France Demierre, host immune defenses can influence the course of malignant neoplasm since it can recognize and neutralize tumor cells. The key to this process is the effective...

  • Gene Expression Signature for Spontaneous Cancer Regression in Melanoma Pigs. Rambow, Florian; Piton, Guillaume; Bouet, Stephan; Leplat, Jean-Jaques; Baulande, Sylvain; Marrau, Angelique; Stam, Mark; Horak, Vratislav; Vincent-Naulleau, Silvia // Neoplasia;Jul2008, Vol. 10 Issue 7, p714 

    Incomplete spontaneous regression of melanoma is common. However, complete melanoma regression is still a very rare phenomenon. Because melanoma is the most immunogenic human malignancy, the mechanisms leading to regression, based on accumulative evidence, are the host's immune responses....

  • PTEN functions as a melanoma tumor suppressor by promoting host immune response. Dong, Y.; Richards, J-AE; Gupta, R.; Aung, P. P.; Ermley, A.; Kluger, Y.; Dogra, S. K.; Mahalingam, M.; Wajapeyee, N. // Oncogene;9/18/2014, Vol. 33 Issue 38, p4632 

    Cancer cells acquire several traits that allow for their survival and progression, including the ability to evade the host Immune response. However, the mechanisms by which cancer cells evade host immune responses remain largely elusive. Here we study the phenomena of immune evasion in malignant...

  • Immunohistological localization of alpha, mu and pi class glutathione S-transferases in skin... Campbell, John A.H.; Corrigall, Anne V. // South African Journal of Science;Feb95, Vol. 91 Issue 2, p101 

    Examines the distribution of the three classes of gluthatione S-transferases (GST) in human melanomas and benign intradermal naevi. Includes cell lines from malignant melanomas; Pi class GST in melanomas; Variations in the strength of the pi reaction; Plasma membrane of malignant melanomas;...

  • Whole Body Melanoma Transcriptome Response in Medaka. Schartl, Manfred; Shen, Yingjia; Maurus, Katja; Walter, Ron; Tomlinson, Chad; Wilson, Richard K.; Postlethwait, John; Warren, Wesley C. // PLoS ONE;12/29/2015, Vol. 10 Issue 12, p1 

    The incidence of malignant melanoma continues to increase each year with poor prognosis for survival in many relapse cases. To reverse this trend, whole body response measures are needed to discover collaborative paths to primary and secondary malignancy. Several species of fish provide...

  • New strategies in melanoma: Vaccines and chemoprevention. Stephenson, Michelle // Dermatology Times;May2005, Vol. 26 Issue 5, p66 

    The article discusses various types of strategies used to treat melanoma. Vaccines and chemoprevention are the two types of strategies used for treating melanoma. In melanoma, there is strong evidence for the relevance of cell-mediated immunity. There is a relation between response to tumor...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics